Kardigan Inc.
KARD | NASDAQ
$14.13
-$0.18 (-1.26%)
At close: Oct 30, 2026, 4:00 PM ET
$14.13
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Company Profile
Kardigan, Inc. is a clinical-stage precision therapeutics company, which engages in developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist. It combines clinical-stage drug programs with artificial intelligence, real-world patient data, and analytics through its “Cardiac Intelligence” platform to accelerate research and improve treatment outcomes. The company was founded by Tassos E. Gianakakos, Jay Edelberg, Bob McDowell, Leslie Leinwand, and Elizabeth McNally in August 2023 and is headquartered in Princeton, NJ.
Key Executives
| Name | Position |
|---|---|
| Tassos Anastasios E. Gianakakos | Co-Founder, President, CEO & Chairman |
| Brianne Puglisi | Chief Financial Officer |
| John Moriarty Jr. ESQ. | Chief Legal Officer & Corporate Secretary |
| Bob McDowell | Co-founder & Scientific Advisor |
| Clayton Robertson | Vice President of Investor Relations |
| Donald Mackenzie | Chief Technical Operations Officer |
| Elizabeth McNally | Co-Founder |
| Emily Faucette | Chief Communications Officer |
| Jay Edelberg | Co-founder & Chief Medical Officer |
| Leslie A. Leinwand | Co-Founder |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 01, 2026 | 4 | Filing |
| Oct 01, 2026 | 3 | Filing |
| Oct 01, 2026 | SC 13D/A | [Amend] Filing |
| Sep 30, 2026 | 8-K | Current Report |
| Aug 13, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Aug 13, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Aug 11, 2026 | 10-Q | Quarterly Report |
| Aug 11, 2026 | 8-K | Current Report |
| Aug 07, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 06, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
Kardigan Inc.
| Country | United States |
| IPO Date | Jun 18, 2026 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 241 |
| CEO | Tassos Gianakakos |
Contact Details
506 Carnegie Center Drive Princeton,
New Jersey 08540 United States
Stock Details
| Ticker Symbol | KARD |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0002123613 |
| CUSIP Number | 485925101 |
| ISIN Number | US4859251013 |
| SIC Code | 2834 |
Recent News
- 1 month ago / businesswire.comKardigan Announces Appointment of Kristin Reinke to its Board of Directors
- 3 months ago / businesswire.comKardigan Reports Second Quarter 2026 Financial Results and Recent Business Updates
- 4 months ago / businesswire.comKardigan Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
Add to Watchlist
Select watchlists to add or remove KARD